Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 105, 1997 - Issue 7
29
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Rats Receiving the Slimming Agent Oleoyl-Estrone in Liposomes (Merlin-2) Decrease Food Intake but Maintain Thermogenesis

, , , , , , , , & show all
Pages 663-672 | Published online: 03 Oct 2008
 

Abstract

Oleoyl-estrone given i.v. – incorporated in liposomes to mimic lipoprotein delivery – (Merlin-2) to normal weight rats, induces a dose-dependent weight loss. Analysis of body composition showed that body protein concentration was preserved and fat stores wasted. The respiratory quotient was consistent with the massive oxidation of body fat, since the diet contained practically no lipid. Appetite was affected by Merlin-2, and thus food intake showed a transient decrease. But oxygen consumption (and basal metabolic rates) was kept practically unchanged at the levels of the controls, i. e. higher than needed to oxidize the food ingested during the weight loss period. Brown adipose tissue uncoupling protein levels were proportionally preserved with a 2-week treatment, but it lost a substantial amount of lipid. In conclusion, Merlin-2 is a slimming agent with considerable potential given its powerful fat-wasting action, since it maintains thermogenesis despite lowered energy intake.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.